Search results: T-ALL

Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL

Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL

Biomedicine

By Invited Researcher

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with a poor prognosis and limited options for targeted therapies . Since the targeted therapies benefiting T-ALL are still limited owing to the biological heterogeneity of T-ALL , identifying novel “druggable” molecular markers and illustrating the underlying mechanisms are immediate pressing issues in T-ALL […]

Biomarkers of chemoresistant leukemic cells in human T-ALL

Biomarkers of chemoresistant leukemic cells in human T-ALL

Biomedicine

By Invited Researcher

T-cell acute lymphoblastic leukemia (T-ALL) is characterized by the accumulation of genetic lesions that induce differentiation arrest, survival and aberrant proliferation of immature T-cell progenitors . Although T-ALL prognosis has significantly improved due to intensive chemotherapy, relapses still occur in 20% of pediatric patients and 50% of adult patients, often with a dismal outcome. To […]

Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-ALL

Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-ALL

Biomedicine

By Invited Researcher

T-cell acute lymphoblastic leukemia (T-ALL) is a hematological malignancy that affects both children and adults. Although with current chemotherapy regimens cure is achieved in ~80% of pediatric patients, adults fare more poorly with only 40% 5-year overall survival . Restricted cellular subsets with asymmetrically enriched leukemia-initiating cell (LIC) activity have been reported in human and […]

Inhibition of Hypoxia-Inducible Factor Alpha (HIF-1α) helps suppress T-ALL drug resistance

Inhibition of Hypoxia-Inducible Factor Alpha (HIF-1α) helps suppress T-ALL drug resistance

Biomedicine

By Invited Researcher

Hypoxia Author: Marta Irigoyen is a postdoctoral researcher at CIC bioGUNE Despite the fact that c ancer treatments have greatly improved during recent years, chemoresistance remains a major problem in eradicating cancer cells. Drug resistance involves not only many cell intrinsic mechanisms but also extrinsic induced chemoprotection by the tumor microenvironment . In fact, this […]

MI weekly selection #590

MI weekly selection #590

Weekly Selection

By César Tomé

Whale songs reveal similarities to human speech Two new studies reveal that whale songs share sophisticated similarities with human speech, challenging the uniqueness of human language. Researchers found that humpback whales exhibit communication efficiency akin to human languages, adhering to linguistic laws such as Menzerath’s and Zipf’s laws. Full Story: ScienceAlert Birds, mammals evolved complex […]

Adipocytes orchestrate T-cell acute lymphoblastic leukemia propagation

Adipocytes orchestrate T-cell acute lymphoblastic leukemia propagation

Biomedicine

By Invited Researcher

T-cell acute lymphoblastic leukemia (T-ALL) is a devastating disease of T-cell progenitors that mainly affects children and young adults. Numerous genomic alterations are known to induce survival, proliferation, and differentiation of T-ALL cells . The interactions between leukemic cells and their microenvironment are known factors that contribute to T-ALL pathogenesis. The bone marrow (BM) microenvironment […]

CASZ1 promotes T-cell acute lymphoblastic leukemia

CASZ1 promotes T-cell acute lymphoblastic leukemia

Biomedicine

By Invited Researcher

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that results from transformation and clonal expansion of developmentally-arrested T-cell progenitors . Conventional risk-adjusted multi-agent chemotherapy allows for high 5-year event-free survival rates in children. However, a significant number of patients still relapse or do not respond to therapy. Consequently, there have been considerable efforts […]

p21 is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia

p21 is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia

Biomedicine

By Invited Researcher

Phagocytosis Author: Marta Irigoyen is a postdoctoral researcher at CIC bioGUNE Phagocytosis of cancer cells by tumor-associated macrophages (TAMs), which are abundant in the tumor microenvironment (TME), plays a critical role in cancer immunosurveillance . Cancer cells can evade macrophage-mediated phagocytosis (the process by which a cell uses its plasma membrane to engulf particles or […]